RNA therapeutics can be applied to a variety of CVDs, including hypercholesterolemia, heart failure, and vascular inflammation. For instance, siRNA targeting apolipoprotein B (mipomersen) has been used to treat homozygous familial hypercholesterolemia. Here, APOB is linked to heart failure.